The American Association for Cancer Research (AACR) annual meeting is a much-anticipated event that inspires cross-pollination among the most innovative cancer researchers in the United States.
This year the meeting will be held in San Diego and some of our Providence Cancer Institute researchers will be there to present their study findings.
Oral Presentation
Abstract CT029: Five-year survival with tebentafusp in previously untreated metastatic uveal melanoma in a phase 3 trial
Authors: Brendan Curti, et al.
Authors: Matthew Taylor, et al.
Poster Presentations
Abstract 613: Bap1 driven soft tissue sarcomas: Mouse modeling and therapeutic strategies.
Authors: Bryan R. Bell, Jianguo Huang, et al.
Abstract 5979: RASurgence: ARF6 boosts RAS oncoprotein synthesis and accelerates tumor progression
Authors: Allie H. Grossmann, et al.
Authors: Prakash Ambady, Andrew Weinberg, et al.
Authors: Matthew Taylor, Thomas Duhen, Brady Bernard, William Redmond, Carlo Bifulco, R. Bryan Bell, Jianguo Huang, Eric Tran, Brian Piening, Rom Leidner, Bernard Fox, et al.
Abstract CT123: Immune escape via myeloid-derived suppressor cells in solid tumor cancer patients treated with anchored IL-12? (tolododekin alfa)
Authors: Brendan Curti, et al.
Authors: Rom Leidner, Prakash Ambady, Christopher Darus, BinBin Zheng, Bernard Fox, William Redmond, Matthew Taylor, et al.
Authors: Rachel Sanborn, et al.
Abstract LB419: Dose escalation and expansion of nivolumab plus relatlimab (NIVO + RELA) in solid tumors in RELATIVITY 020 Parts A-C
Authors: Rachel Sanborn, et al.
About Providence Cancer Institute of Oregon
Providence Cancer Institute in Oregon is a leading provider of cancer care in Oregon and a global leader in immuno-oncology. Through its research division, the Earle A. Chiles Research Institute, patients have access to state-of-the-art genomic sequencing, adoptive cellular therapies and a robust clinical research portfolio comprising early phase, investigator-initiated, cooperative group and industry-sponsored trials. Our multidisciplinary care teams partner with patients at every step of care, from prevention and diagnosis to personalized treatment plans, support services and cancer survivorship.
Learn more at www.providence.org/ORcancer.
